SF 2062: Relating to insurance coverage for prescription insulin drugs

What it does

This bill relates to prescription insulin drugs and coverage by policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs. The bill requires a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses that provides coverage for prescription drugs to cap the total amount of cost-sharing that a covered person is required to pay per prescription filled of an insulin drug to an amount not more than $25 for an up to 31-day supply of at least one type of rapid-acting prescription insulin drugs, short-acting prescription insulin drugs, intermediate-acting prescription insulin drugs, or long-acting prescription insulin drugs.

Senate subcommittee · named January 24, 2024

• Sen. Mike Bousselot (R) · mike.bousselot@legis.iowa.gov
• Sen. Dan Dawson (R) · dan.dawson@legis.iowa.gov
• Sen. Janet Petersen (D) · janet.petersen@legis.iowa.gov

Lobbying · 1 for, 1 against

For: Iowa Retired School Personnel Association

Against: Wellmark, Inc.

In plain words

1. January 17, 2024Filed in the Senate and sent to the Commerce committee
2. January 24, 2024Senate subcommittee named: Bousselot, Dawson and Petersen